Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial

·2002·The Lancet

Abstract

Background It has been suggested that increased intake of various antioxidant vitamins reduces the incidence rates of vascular disease, cancer, and other adverse outcomes.Methods 20,536 UK adults (aged 40-80) with coronary disease, other occlusive arterial disease, or diabetes were randomly allocated to receive antioxidant vitamin supplementation (600 mg vitamin E, 250 mg vitamin C, and 20 mg beta-carotene daily) or matching placebo. Intention-to-treat comparisons of outcome were conducted between all vitamin-allocated and all placebo-allocated participants. An average of 83% of participants in each treatment group remained compliant during the scheduled 5-year treatment period. Allocation to this vitamin regimen approximately doubled the plasma concentration of alpha-tocopherol, increased that of vitamin C by one-third, and quadrupled that of beta-carotene. Primary outcomes were major coronary events (for overall analyses) and fatal or non-fatal vascular events (for subcategory analyses), with subsidiary assessments of cancer and of other major morbidity.Findings There were no significant differences in all-cause mortality (1446 [14.1%] vitamin-allocated vs 1389 [13.5%] placebo-allocated), or in deaths due to vascular (878 [8.6%] vs 840 [8.2%]) or non-vascular (568 [5.5%] vs 549 [5.3%]) causes. Nor were there any significant differences in the numbers of participants having non-fatal myocardial infarction or coronary death (1063 [10.4%] vs 1047 [10.2%]), non-fatal or fatal stroke (511 [5.0%] vs 518 [5.0%]), or coronary or non-coronary revascularisation (1058 [10.3%] vs 1086 [10.6%]). For the first occurrence of any of these "major vascular events", there were no material differences either overall (2306 [22.5%] vs 2312 [22.5%]; event rate ratio 1.00 [95% CI 0.94-1.06]) or in any of the various subcategories considered. There were no significant effects on cancer incidence or on hospitalisation for any other non-vascular cause.Interpretation Among the high-risk individuals that were studied, these antioxidant vitamins appeared to be safe. But, although this regimen increased blood vitamin concentrations substantially, it did not produce any significant reductions in the 5-year mortality from, or incidence of, any type of vascular disease, cancer, or other major outcome.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(02)09328-5

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 67 references

Research works printed but not linked: 2

  1. Christen, 2001, Beta-carotene and age-related cataract in a randomized trial of US physicians, IOVS, 42, S518
  2. Keech, 1992, Vitamin E supplementation inhibits LDL oxidation in patients at risk of coronary disease taking simvastatin or placebo, XI Int Symp Drugs Lip Met, 59

Cited by

See all 1,502

Metadata

Venue
The Lancet
Publisher
Elsevier BV
Published
2002-07
Volume
360
Issue
9326
Pages
23-33
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2214291492
Cited by
1,502
References
67
Citations by year
2026: 13 · 2025: 13 · 2024: 21 · 2023: 21 · 2022: 29 · 2021: 33 · 2020: 39 · 2019: 29 · 2018: 26 · 2017: 31 · 2016: 39 · 2015: 48 · 2014: 56 · 2013: 61 · 2012: 72
FWCI
83.07
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • The Lancet
Funders
British Heart Foundation
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
vitamin E, vitamin C, beta-carotene, coronary artery disease, vascular disease, stroke, myocardial infarction, revascularization, all-cause mortality, cancer incidence, high-risk patients, plasma vitamin levels, medication adherence
MeSH terms
Adult, Aged, Aged, 80 and over, Antioxidants, Ascorbic Acid, Cardiovascular Diseases, Cause of Death, Cholesterol, Coronary Disease, Diabetes Mellitus, Female, Follow-Up Studies, United Kingdom, Humans, Male, Middle Aged, Neoplasms, Severity of Illness Index, Vitamin E, beta Carotene, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(02)09328-5
The paper
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. (2002). The Lancet. https://doi.org/10.1016/s0140-6736(02)09328-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.